Phase III randomized double blind placebo-controlled trial of FavId and GM-CSF versus placebo and GM-CSF following rituximab in subjects with follicular B-cell non-Hodgkin's lymphoma
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Mitumprotimut T (Primary) ; Rituximab; Sargramostim
- Indications B cell lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Registrational; Therapeutic Use
- 04 May 2009 Full results have been reported in the Journal of Clinical Oncology.
- 09 Apr 2008 Data analysis and unblinding is expected in June 2008 according to a Favrille media release.
- 19 Feb 2008 Favrille have reported that data collection is on schedule with the final analysis expected no later than July 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History